Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study

W Jonat, M Kaufmann, W Sauerbrei, R Blamey, J Cuzick, M Namer, I Fogelman, J C de Haes, A de Matteis, A Stewart, W Eiermann, I Szakolczai, M Palmer, M Schumacher, M Geberth, B Lisboa

Research output: Contribution to journalArticlepeer-review

320 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science